Search company, investor...

Yaoshibang

ysbang.cn

Total Raised

$497.19M

Investors Count

15

Deal Terms

2

Funding, Valuation & Revenue

6 Fundings

Yaoshibang's latest funding round was a Series E for $270M on June 15, 2021.

Yaoshibang's valuation in June 2018 was $468.57M.

Yaoshibang's latest post-money valuation is from June 2021.

Sign up for a free trial to see Yaoshibang's valuations in June 2021 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/15/2021

Series E

$270M

$99M

0

FY undefined

6

12/16/2018

Series D

$99M

0

FY undefined

10

6/14/2018

Series C

$99M

$468.57M

0

FY undefined

10

2/8/2017

Series B

$99M

0

FY undefined

10

4/6/2016

Series A

$99M

0

FY undefined

10

Date

6/15/2021

12/16/2018

6/14/2018

2/8/2017

4/6/2016

Round

Series E

Series D

Series C

Series B

Series A

Amount

$270M

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

$468.57M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

6

10

10

10

10

This profile has not been claimed.

You're more than your latest funding, tell our customers your company's story.

Yaoshibang Deal Terms

2 Deal Terms

Yaoshibang's deal structure is available for 2 funding rounds, including their Series E from June 15, 2021.

Round

Series E

Series C

Funding Date

$99M

$99M

Pre-Money Valuation

$99M

$99M

Post-Money Valuation

$99M

$99M

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series E

$99M

$99M

$99M

$99M

$99M

$99M

Series C

$99M

$99M

$99M

$99M

$99M

$99M

Yaoshibang Investors

15 Investors

Yaoshibang has 15 investors. Green Pine Capital Partners invested in Yaoshibang's Series E funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

2/8/2017

6/15/2021

3
Series B, Series C (2018), Series E (2021)

Venture Capital

China

6/15/2021

6/15/2021

1
Series E

Corporation

China

6/15/2021

6/15/2021

1
Series E

Corporation

China

00/00/0000

00/00/0000

Baidu

Subscribe to see more

Corporation

China

00/00/0000

00/00/0000

Pearl River Investments

Subscribe to see more

Corporation

China

First funding

2/8/2017

6/15/2021

6/15/2021

00/00/0000

00/00/0000

Last Funding

6/15/2021

6/15/2021

6/15/2021

00/00/0000

00/00/0000

Investor

Baidu

Pearl River Investments

Rounds

3
Series B, Series C (2018), Series E (2021)
1
Series E
1
Series E

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Corporation

Corporation

Corporation

Corporation

Location

China

China

China

China

China

Compare Yaoshibang to Competitors

Truepill Logo
Truepill

Truepill offers an online pharmacy that provides telehealth services, patient-facing brands, and solutions for health brands, pharmaceutical manufacturers, and health plan providers. The company also offers telehealth and diagnostics services alongside the company's pharmacy service. It provides a virtual pharmacy, which serves as a white-labeled pharmacy e-commerce platform for others. It caters to the pharmaceutical sector. The company was founded in 2016 and is based in Hayward, California.

Ro Logo
Ro

Ro is a patient-driven telehealth company that puts patients in control of their health. The company builds technology to make healthcare accessible, affordable, and enjoyable. Ro powers three digital health clinics: Roman for men’s health, Rory for women’s health, and Zero for fighting smoking cessation. It also operates Ro Pharmacy, a simple and affordable online pharmacy where every generic medication is $5 per month. Ro’s nationwide network of physicians and pharmacies provides a personalized, end-to-end healthcare experience from online treatment to the delivery of medication and ongoing care. The company was founded in 2017 and is based in New York, New York.

Alto Pharmacy Logo
Alto Pharmacy

Alto Pharmacy provides same-day, free delivery, seven days a week for prescriptions, offering cost transparency, personalized in-app and phone support, and real-time coordination with doctors and insurance companies.

p
phil

Phil is a software therapy deployment platform, offering pharmaceutical manufacturers a modern alternative to traditional access, affordability and distribution options. Through its digital stakeholder experiences, patient access services, market access solutions and distribution models, pharma manufacturers are able to deliver affordable and timely therapy access to patients.

Remedi Seniorcare Logo
Remedi Seniorcare

Remedi SeniorCare delivers comprehensive pharmacy services, pharmacy consulting, and data management services to nursing homes, assisted living, and continuing care retirement communities. The business is committed to helping these organizations achieve outstanding care, financial strength, and medication safety. Remedi combines their culture of caring with real-world pharmacy services and best-in-class technology to give organizations more time and resources and help them focus on caring for their residents.

Kit Check Logo
Kit Check

Kit Check provides cloud based and Internet of Things (IoT) hospital pharmacy kit processing and medication tracking software which replaces time consuming and error prone manual processes for hospital medication handling.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.